222 related articles for article (PubMed ID: 32162011)
1. Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.
Song J; Zhang N; Cao L; Xiao D; Ye X; Luo E; Zhang Z
Int J Clin Oncol; 2020 Jun; 25(6):1072-1078. PubMed ID: 32162011
[TBL] [Abstract][Full Text] [Related]
2. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
3. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma.
Liao L; Wang J; Ouyang S; Zhang P; Wang J; Zhang M
Med Sci Monit; 2015 Mar; 21():776-81. PubMed ID: 25791131
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.
Luo C; Pu J; Liu F; Long X; Wang C; Wei H; Tang Q
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):715-721. PubMed ID: 30962170
[TBL] [Abstract][Full Text] [Related]
7. MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.
Yan Y; Yan F; Huang Q
Arch Oral Biol; 2018 Dec; 96():52-57. PubMed ID: 30179745
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
[TBL] [Abstract][Full Text] [Related]
9. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
Ni ZY; Lin FO; Liu DF; Xiao J
Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
11. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
Zhang D; Ni Z; Xu X; Xiao J
Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
[TBL] [Abstract][Full Text] [Related]
12. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
Sun L; Liu L; Fu H; Wang Q; Shi Y
Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
[TBL] [Abstract][Full Text] [Related]
13. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
15. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
16. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
[TBL] [Abstract][Full Text] [Related]
17. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
Hu S; Wang H; Yan D; Lu W; Gao P; Lou W; Kong X
Cell Cycle; 2018; 17(18):2284-2295. PubMed ID: 30252587
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
19. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
